Pediatrix Medical Group (NYSE:MD) Shares Up 4.9% – Still a Buy?

Pediatrix Medical Group, Inc. (NYSE:MD) was up 4.9% on Tuesday . The company traded as high as $14.67 and last traded at $14.66. Approximately 209,974 shares changed hands during mid-day trading, a decline of 54% from the average daily volume of 455,716 shares. The stock had previously closed at $13.98.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on MD. Truist Financial lowered their price target on Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating on the stock in a research report on Monday, January 6th. Jefferies Financial Group upped their price objective on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. UBS Group lifted their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday, November 5th. Mizuho upped their price target on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $16.25.

Pediatrix Medical Group Price Performance

The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. The stock’s 50 day simple moving average is $13.85 and its two-hundred day simple moving average is $12.61. The firm has a market capitalization of $1.26 billion, a PE ratio of -4.82, a price-to-earnings-growth ratio of 1.38 and a beta of 1.57.

Insiders Place Their Bets

In other Pediatrix Medical Group news, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total value of $423,660.00. Following the sale, the director now owns 138,683 shares in the company, valued at $2,128,784.05. The trade was a 16.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently modified their holdings of MD. Quest Partners LLC boosted its holdings in Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares during the period. Everence Capital Management Inc. boosted its position in Pediatrix Medical Group by 7.5% in the 4th quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock valued at $182,000 after buying an additional 960 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after acquiring an additional 1,040 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of Pediatrix Medical Group by 3.5% during the second quarter. The Manufacturers Life Insurance Company now owns 32,387 shares of the company’s stock worth $245,000 after acquiring an additional 1,088 shares during the period. Finally, Quarry LP raised its stake in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.